Qian et al. (2022) demonstrated a significant increase in NFE2L3 expression in bladder cancer (BLCA) samples compared to normal tissues and found a strong correlation between high levels of NFE2L3 and advanced clinicopathological features, as well as poor prognosis. The gene discussed is NFE2L3; the disease is bladder transitional cell carcinoma.